QR PHARMA INC has a total of 16 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are FARMA DERMA S R L, LP PHARMACEUTICAL XIAMEN CO LTD and AUNG-DIN RONALD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Maccecchini Maria | 14 |
#2 | Maria Maccecchini | 2 |
Publication | Filing date | Title |
---|---|---|
EP3654957A1 | Prevention or treatment of disease states due to metal dis-homeostasis via administration of posiphen to healthy or sick humans | |
TW201717938A | Methods of treatment or prevention of acute brain or nerve injuries | |
BR112013022673A2 | amount of phenylcarbamate, and method for inhibiting the production of a neurotoxic aggregation protein in an individual | |
WO2012058031A2 | Novel method for preparation of bisnorcymerine and salts thereof |